TSS Clinical Trials Digitalization User Forum 2021
Document
We’re pleased to announce the first TSS Clinical Trials Digitalization User Forum on February 10-11, 2021
How can digitalization transform trials while maintaining quality standards that ensure safe medicine?
What is on this page?
Click to jump to a specific section below.
Digitalization to transform clinical trials to ensure a safe drug to every patient
Together with our most valued partners, we are hosting two half-day virtual sessions with interactive content addressing value-adding digital transformation in clinical trials.
This by-invitation-only user forum set out to discuss best practices for streamlining clinical trial costs and efforts by utilizing digital technologies while moving more towards a patient-centered trial experience.
Some of the topics discussed during the forum were:
- Leveraging IoT to transform clinical trials and lower costs in 2021
- Ensuring a safe drug to every patient with Digital health and Remote inspections
- Creating a holistic end-to-end view that drives sustainability and reduces waste
- Transforming the future. New solutions available
In case you would like to get more information about the event, please contact us.
You may also be interested in
On time and in full, when it matters most
When TSS received the request to support Sandoz, the Novartis generics and biosimilar division, from its client Novartis, a multinational pharmaceutical company based in Switzerland, citing their need for urgent support with surveillance of critical shipments related to a COVID-19, the obvious solution was TSS Real-Time Monitoring solution.
Read moreDownload Whitepaper.avif)
TSS Welcomes Thomas Lindén as New Chief Technology Officer
TSS, a leading temperature monitoring solutions provider, is pleased to announce the appointment of Thomas Lindén as its new Chief Technology Officer (CTO). In this role, Thomas Lindén will play a crucial part in shaping the company's technological landscape and driving its growth strategies.
Read moreDownload Whitepaper
How GSK Pharma in UAE optimized the supply chain through automatization
Is it possible to cut costs, increase efficiency, and improve quality—all at the same time? The GSK (GlaxoSmithKline) UAE division and their main logistics company GAC (Gulf Agency Company) exceeded their expectations when they implemented temperature monitoring solutions from TSS in outbound shipments from Dubai. Additionally, they reassured the safety of what's most valuable—the patient.
Read moreDownload WhitepaperYou may also be interested in
What Do EMA’s Updated Shortage Prevention Guidelines Mean for Pharmaceutical Leaders?
The European Medicines Agency has updated its guidance and template for Shortage Prevention Plans. For pharmaceutical leaders, the development is more than a regulatory planning exercise. It is an invitation to examine whether their organizations can identify supply vulnerabilities early and respond before an issue affects medicine availability.
Read more
Extending TempMonitor BLE to Ultra-Low Temperatures
Introducing the new TSS Dry Ice Probes, enginereed for accurate and GxP-compliant temperature monitoring down to –90°C. Available in two lengths for flexible setup — built to safeguard product integrity in every environment.
Read more